Search clinical trials for: Glucagon-like peptide-1 (GLP-1) analogs

Total 48535 results

Shahid Beheshti University of Medical Sciences
praxisgemeinschaft für zelltherapie

Unknown

Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection

Covid19 | Corona Virus Infection | Treatment

Iran, Islamic Republic of
GlyPharma Therapeutics
VectivBio AG

Completed

Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support

Short Bowel Syndrome

Denmark
Pfizer

Terminated

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
Hoffmann-La Roche

Completed

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Diabetes Mellitus Type 2

Australia, United States, France, Germany, Mexico, Puerto Rico, Peru
University Hospital, Gentofte, Copenhagen
Merck Sharp & Dohme LLC

Completed

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Denmark
University of Copenhagen
Hvidovre University Hospital

Completed

Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes (NEPT2D)

Type2 Diabetes

Denmark
Aarhus University Hospital Skejby
Aarhus University Hospital; University of Aarhus

Completed

Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure

Heart Failure, Congestive

Denmark
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Obesity

Australia
Vanderbilt University

Completed

Pharmacogenetics of Ace Inhibitor-Associated Angioedema

Hypertension | Diabetes Type 2

United States
Sanofi

Completed

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure (GAUDI)

Type 2 Diabetes Mellitus

Japan
Mikkel Christensen

Completed

Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes

Type 1 Diabetes Mellitus
Sanofi

Completed

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin (GETGOAL-L)

Diabetes Mellitus, Type 2

United States, France, Canada, Brazil, Russian Federation, Germany, Italy, Turkey, India, Mexico, Egypt, United Kingdom, Korea, Republic of, Chile, Puerto Rico
University of Copenhagen
The Danish Medical Research Council

Completed

The Interaction Between Appetite Hormones

Obesity

Denmark
Hvidovre University Hospital

Completed

Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus

Type 1 Diabetes

Denmark
University of Liege

Unknown

Light Therapy in Disorders of Consciousness: Behavioral, Neuroimaging and (Neuro)Physiological Assessments.

Disorder of Consciousness
Jesper Kjaergaard

Completed

GLP-1 Analogs for Neuroprotection After Cardiac Arrest (GLIP1)

Cardiac Arrest | Coma

Denmark
Tianjin Medical University Cancer Institute and...

Recruiting

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

Breast Cancer

China
Chinese PLA General Hospital

Completed

Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction

Coronary Angiography | Glucagon-like Peptide-1
Antonio Di Mauro

Completed

GLP-1 and Oxyntomodulin Release in Relation to Diet in Type 2 Diabetes Patients. (VAS)

Type-2 Diabetes

Italy
Amsterdam UMC, location VUmc

Completed

Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes (LIBRA)

Obesity | Type 2 Diabetes

Netherlands
Hadassah Medical Organization

Unknown

GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients

Uncontrolled Type 1 Diabetic Patients
Shanghai 10th People's Hospital

Unknown

Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status

Obesity

China
Second Xiangya Hospital of Central South University
Guangdong Provincial People's Hospital; The First Affiliated Hospital of Henan... and other collaborators

Recruiting

The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.

Diabetes Mellitus, Type 2 | Overweight or Obesity

China
AstraZeneca

Not yet recruiting

A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure (LUMINARA)

Chronic Heart Failure
CellMed AG, a subsidiary of BTG plc.

Terminated

GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Intracerebral Hemorrhage (ICH)

Germany
University Hospital, Gentofte, Copenhagen

Completed

Bileacid Malabsorption and GLP-1 Secretion

Bileacid Malabsorption

Denmark
Mayo Clinic
Astellas Pharma US, Inc.; University of Nebraska; Lantheus Medical Imaging

Completed

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes (GLP-1)

Coronary Artery Disease | Diabetes Mellitus Type 2

United States
Cedars-Sinai Medical Center

Withdrawn

Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation

Type 2 Diabetes

United States
Ramathibodi Hospital
Merck Sharp & Dohme LLC

Completed

The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers (Sleep GLP-1)

Prediabetes

Thailand
University Health Network, Toronto
Novo Nordisk A/S

Withdrawn

Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study (PLAQUE)

Psoriasis | Type 2 Diabetes | Impaired Glucose Tolerance | Psoriatic Arthritis

Canada
Beth Israel Deaconess Medical Center

Completed

Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

Diabetes | Weight Loss | Hunger | Effects of Liraglutide Administration on Brain Activity

United States
University of Copenhagen

Completed

Diet Oil Induced Stimulation of GLP-1

Type 2 Diabetes Mellitus

Denmark
Hasan Kalyoncu University

Recruiting

Study of the Effect of Compassion-Based Education Program Applied to Mothers of Children Diagnosed With Cerebral Palsy

Cerebral Palsy

Turkey
Radboud University Medical Center
AstraZeneca

Completed

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Hypoglycemia | Diabetes Mellitus, Type 1

Netherlands
University of Copenhagen
Danisco

Completed

The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man (M192)

Insulin Resistance

Denmark
EZUS-LYON 1

Active, not recruiting

CARdioprotection in Myocardial Infarction (CARIM)

Myocardial Infarct

France
EZUS-LYON 1

Active, not recruiting

The Influence of Manual Therapy Applied to the Cervical Spine in the Prevention of Balance Disorders in the Elderly (ManEq)

Elderly | Gait | Balance, Postural

France
King's College London

Recruiting

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Obesity | Diabetes Mellitus | Mental Health Issue

United Kingdom
Bayer

Active, not recruiting

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice (FINEGUST)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Japan, Spain, Netherlands, Denmark, United States
Suleyman Demirel University

Recruiting

Developing a New Scale for Evaluating Shoulder Problems

Shoulder Injuries | Shoulder Pain | Shoulder Lesions

Turkey
Anders Fink-Jensen, MD, DMSci

Recruiting

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

Schizophrenia | Type 2 Diabetes | Metabolic Disturbance | Clozapine | Olanzapine | GLP-1

Denmark
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants (XW003)

Obesity | Type 2 Diabetes Mellitus | Nonalcoholic Steatohepatitis

Australia
Stanley Dudrick's Memorial Hospital

Terminated

The Use of DPP-4 Inhibitors in Short Bowel Syndrome (DPP-4)

Short Bowel Syndrome

Poland
James J. Peters Veterans Affairs Medical Center
Kessler Institute for Rehabilitation

Completed

Once Weekly GLP-1 in Persons With Spinal Cord Injury

Obesity | Insulin Resistance | Spinal Cord Injuries | Pre Diabetes

United States
University of Copenhagen
Hvidovre University Hospital

Completed

Investigation of GLP-2 Mechanism of Action (GA-8)

Healthy

Denmark
National Institute on Aging (NIA)

Completed

The Role of Phosphodiesterase Inhibitors in Incretin Secretion

Healthy Volunteers

United States
Zydus Lifesciences Limited

Completed

A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers (ZYD1)

Type 2 Diabetes Mellitus

India
Kowa Company, Ltd.
Sanofi

Completed

Tofogliflozin GLP-1 Analogue Combination Trial

Type 2 Diabetes Mellitus

Japan
Cambridge University Hospitals NHS Foundation Trust

Completed

Gastrectomy, Eating Behaviour and GLP-1

Gastric Cancer | Dumping Syndrome

United Kingdom
Papworth Hospital NHS Foundation Trust

Completed

Human Vasodilatory Effect of GLP-1

Angina, Stable | Type2 Diabetes | Coronary Stenosis

Search clinical trials for: Glucagon-like peptide-1 (GLP-1) analogs

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations